Scarica l'app Stockscreener
13.75
3.77%
0.50
Precedente Chiudi:
$13.25
Aprire:
$12.97
Volume 24 ore:
513.12K
Relative Volume:
1.51
Capitalizzazione di mercato:
$459.59M
Reddito:
-
Utile/perdita netta:
$-47.20M
Rapporto P/E:
-8.7843
EPS:
-1.5653
Flusso di cassa netto:
$-43.65M
1 W Prestazione:
-5.63%
1M Prestazione:
+18.43%
6M Prestazione:
+37.36%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$12.55
$13.92
Intervallo di 1 settimana:
$12.55
$15.94
Portata 52W:
$4.8069
$27.50
Mbx Biosciences Inc Stock (MBX) Company Profile
Nome
Mbx Biosciences Inc
Settore
Industria
Telefono
(317) 989-3100
Indirizzo
11711 N. MERIDIAN STREET, CARMEL
Confronta MBX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MBX
Mbx Biosciences Inc
|
13.75 | 442.87M | 0 | -47.20M | -43.65M | -1.5653 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-16 | Iniziato | Oppenheimer | Outperform |
| 2025-04-10 | Iniziato | Citizens JMP | Mkt Outperform |
| 2024-10-08 | Iniziato | Guggenheim | Buy |
| 2024-10-08 | Iniziato | JP Morgan | Overweight |
| 2024-10-08 | Iniziato | Jefferies | Buy |
| 2024-10-08 | Iniziato | Stifel | Buy |
Mostra tutto
Mbx Biosciences Inc Borsa (MBX) Ultime notizie
Applying big data sentiment scoring on MBX Biosciences Inc.2-Day Signal Watch with Forecast Outcome - Newser
What institutional investors are buying MBX Biosciences Inc. stockEntry Signal Alerts With Low Risk - jammulinksnews.com
Is MBX Biosciences Inc. a growth stock or a value stockRetirement Planning Updates For Consistent Profits - jammulinksnews.com
Tools to assess MBX Biosciences Inc.’s risk profileStock Performance Summary Over One Year - Newser
When is MBX Biosciences Inc. stock expected to show significant growthTop Growth Ideas To Watch Now - jammulinksnews.com
Can trapped investors hope for a rebound in MBX Biosciences Inc.Free Step-by-Step Trade Signal Implementation - Newser
What makes MBX Biosciences Inc. stock price move sharplyFree Daily Chart Pattern Stock Forecast - Newser
Applying sector rotation models to MBX Biosciences Inc.Buy Low Sell High Stock Watch Strategy in Focus - metal.it
How MBX Biosciences Inc. stock performs during market volatilityPre-Market Stock Movement Summary and Review - Newser
Published on: 2025-07-29 13:50:43 - metal.it
Sectors Driving Future Growth for MBX Biosciences Inc. StockSwing Candidate List with Trade Cues - Newser
Is MBX Biosciences Inc. Stock a Good Fit for Conservative InvestorsConservative Asset Allocation Risk Analysis - Newser
MBX Biosciences Inc. Breaks Losing Streak — Is the Trend ReversingMarket Entry and Exit Point Tips From Traders - metal.it
MBX Biosciences Inc Inc. (MBX) Price Performance: The Role of Share Buybacks and Stock Splits - investchronicle.com
How does MBX Biosciences Inc. generate profit in a changing economyFind market-beating stocks for your portfolio - jammulinksnews.com
What are the latest earnings results for MBX Biosciences Inc.Maximize returns with disciplined investment techniques - jammulinksnews.com
How to manage a losing position in MBX Biosciences Inc.Trend Following Ideas with Volume Confirmation - Newser
How does MBX Biosciences Inc. compare to its industry peersExceptional gains - jammulinksnews.com
New York State Common Retirement Fund Buys Shares of 4,300 MBX Biosciences, Inc. (NYSE:MBX) - Defense World
How strong is MBX Biosciences Inc. company’s balance sheetFree Stock Market Beginners Guide - jammulinksnews.com
What analysts say about MBX Biosciences Inc. stockHigh-profit stock alerts - PrintWeekIndia
What drives MBX Biosciences Inc. stock priceAccelerated wealth building - PrintWeekIndia
Is MBX Biosciences Inc. a good long term investmentExtraordinary market timing - Autocar Professional
Oppenheimer reiterates Outperform rating on MBX Biosciences stock ahead of Phase 2 data - Investing.com Nigeria
MBX Biosciences Inc. Stock Analysis and ForecastBreakthrough financial growth - jammulinksnews.com
Why MBX Biosciences Inc. stock attracts strong analyst attentionSmart Growth Low Risk Picks - Newser
MBX Biosciences (NYSE:MBX) Coverage Initiated by Analysts at Oppenheimer - MarketBeat
Mbx Biosciences Inc Azioni (MBX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Mbx Biosciences Inc Azioni (MBX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| GORDON CARL L | Director |
Feb 18 '25 |
Buy |
10.84 |
143,170 |
1,551,963 |
3,255,000 |
| GORDON CARL L | Director |
Feb 14 '25 |
Buy |
9.87 |
47,502 |
468,793 |
3,205,930 |
| ORBIMED ADVISORS LLC | Director |
Feb 18 '25 |
Buy |
10.84 |
143,170 |
1,551,963 |
3,255,000 |
| ORBIMED ADVISORS LLC | Director |
Feb 14 '25 |
Buy |
9.87 |
47,502 |
468,793 |
3,205,930 |
| Hawryluk P. Kent | President & CEO |
Feb 04 '25 |
Buy |
10.69 |
50,000 |
534,500 |
448,277 |
| Mathers Edward T | Director |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| BASKETT FOREST | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| Behbahani Ali | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| Chang Carmen | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| Florence Anthony A. Jr. | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
0.93%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):